Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus

Archives of Medical Research

Volumn 35, Issue 2, 2004, Pages 134-140

  Erciyas, Füsun ^a   Taneli, Fatma ^b   Arslan, Banu ^a   Uslu, Yasemin ^c  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

Author keywords

Children; Insulin dependent diabetes mellitus; Lipids; MDA; Oxidative stress

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; ASSOCIATION; CHILD; CHILDHOOD; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLISM; OXIDATIVE STRESS; PEDIATRICS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERGLYCEMIA; LIPID METABOLISM; LIPIDS; MALE; OXIDATIVE STRESS;

EID: 1542328919     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2003.10.002     Document Type: Article

References (28)

1. Gallou G., Ruelland A., Legras B., Maugendere D., Allanic H., Cloarec L. Plasma malondialdehyde in type I and type II diabetic patients. Clin Chim Acta. 214:1993;227-234.
2. Vantyghem M.C., Balduyck M., Zerimech F., Martin A., Douillard C., Bans S., Degand P.M., Lefebvre J. Oxidative markers in diabetic ketoacidosis. J Endocrinol Invest. 23:2000;732-736.
3. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy. 101:(10):2000;541-551.
4. Baynes J.W., Thorpe S.R. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med. 28:(12):2000;1708-1716.
5. Hunt J.V., Bottoms M.A., Clare K., Skamarauskas J.T., Mitchinson M.J. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis. Biochem J. 300:1994;243-249.
6. Hunt J.V., Smith C.C., Wolff S.P. Autooxidative glycosylation and possible involvement of peroxidase and free radicals in LDL modification by glucose. Diabetes. 39:1990;1420-1424.
7. Wittenstein B., Klein M., Finckh B., Ullrich K., Kohlschutter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med. 33:(1):2002;103-110.
8. Jakus V., Bauerova K., Michalkova D., Carsky J. Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus. Bratisl Lek Listy. 101:(9):2000;484-489.
9. Varvarovska J., Racek J., Stozicky F., Soucek J., Trefil L., Pomahacova R. Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives. J Diabet Complic. 17:2003;7-10.
10. Guerci B., Antebi H., Meyer L., Durlach V., Ziegler O., Nicolas J.P., Alcindor L.G., Droulin P. Increased ability of LDL from normolipidemic type I diabetic women to generate peroxides. Clin Chem. 45:(9):1999;1439-1448.
11. Domínguez C., Ruitz E., Gussinye M., Carrascosa A. Oxidative stress at onset and in early stage of type 1 diabetes in children and adolescent. Diabet Care. 21:(10):1998;1736-1742.
12. Pitkanen O.M., Martin J.M., Tallman M., Akerblom H., Andersson S.M. Free radical activity during development of type-I diabetes mellitus in rat. Life Sci. 50:1992;335-339.
13. Nacitarhan S., Özben T., Tuncer N. Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia. Free Radic Biol Med. 19:1995;893-896.
14. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: Diagnosis and classification of diabetes mellitus provisinal report of a WHO consultation. Diabet Med. 15:1998;539-553.
15. Stocs J., Dormandy T.L. The autooxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol. 20:1971;95-111.
16. Aliciguzel Y., Ozdem S.N., Ozdem S.S., Karayalçin U., Siedlak S., Perry G., Smith M.A. Erythrocyte, plasma and serum antioxidant activities in untreated toxic multinodular goiter patients. Free Rad Biol Med. 30:2001;665-670.
17. Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
18. Verg'es B.L. Dyslipidemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab. 25:1999;32-40.
19. Yoshino G., Hirano T., Kazumi T. Dyslipidemia in diabetes mellitus. Diabetes Res Clin Pract. 33:1996;1-14.
20. Kondo A., Muranaka Y., Ohta I., Notsu K., Manabe M., Kotani K., Saito K., Maekawa M., Kanno T. Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL. Clin Chem. 47:(5):2001;893-900.
21. 1c. Acta Paediatr Scand. 74:1985;966-971.
22. Ewald U., Gustafson S., Tuvemo T., Vessby B. Increased high density lipoproteins in diabetic children. Eur J Pediatr. 142:1984;154-156.
23. Andersen G.E., Christiansen J.S., Mortensen H.B., Christiansen K.M., Pedersen-Bjergaard L., Kastrup K.W., Vestermark S. Plasma lipids and lipoproteins in type-I diabetic children and adolescent in relation to metabolic regulation, obesity and genetic hyperlipoproteinemia. Acta Paediatr Scand. 72:1983;361-365.
24. Ohta T., Nishiyama S., Nakamura T., Saku K., Maung K.K., Matsuda I. Predominance of large low density lipoprotein particles and lower fractional esterefication rate of cholesterol in high density lipoprotein in children with insulin-dependent diabetes mellitus. Eur J Pediatr. 157:1998;276-281.
25. Hayashibe H., Asayama K., Nakane T., Kobayashi K., Amemiya S., Nakazawa S. Decreased activity of plasma cholesteryl ester transfer protein in children and adolescent with insulin-dependent diabetes mellitus. Acta Paediatr. 88:1999;1067-1070.
26. al Muhtaseb N., al Yousuf A., Bajaj J.S. Apolipoprotein A-I, A-II, B, C-II and C-III in children with insulin-diabetes mellitus. Pediatrics. 89:1992;936-941.
27. Taylor K.G., John W.G., Matthews K.A., Wright A.D. A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type II (non-insulin-dependent) diabetes. Diabetelogia. 23:1982;507-510.
28. Noberasco G., Odetti P., Boeri D., Maiello M., Adezati L. Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin. Biomed Pharmacother. 45:1991;193-196.